Toast insider sales: 124,509 shares planned; 385,000 shares sold for $17.27M
Rhea-AI Filing Summary
Toast insider Christopher P. Comparato filed a Form 144 to sell 124,509 Class A shares through Fidelity on the NYSE, with an aggregate market value of $5,418,867.08. The proposed sale is dated 08/11/2025 and the filing reports 510,000,000 shares outstanding, making the block a small fraction of the company stock. The securities were acquired by option (grant dated 02/08/2019) and the payment method is listed as cash. The filer disclosed prior sales of 385,000 shares in the past three months for aggregate gross proceeds of $17,266,795.00. The form includes the required representation that no undisclosed material adverse information is known.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider Christopher P. Comparato plans a sale of 124,509 Class A shares (~$5.42M); prior three-month sales totaled 385,000 shares (~$17.27M).
The filing is a standard Rule 144 notice showing an insider exercise of options granted 02/08/2019 and immediate or planned sale on 08/11/2025 through Fidelity on the NYSE. The disclosed block represents a very small percentage of the 510,000,000 shares outstanding, suggesting limited direct impact on share supply. The recent pattern of sales over the past three months is explicitly reported and totals 385,000 shares for $17,266,795.00, which is relevant for monitoring insider liquidity but does not, on its face, disclose any undisclosed adverse company information.
TL;DR: The Form 144 shows compliant insider disclosure of option-derived shares being sold for cash, with prior recent sales also disclosed.
This filing demonstrates compliance with disclosure rules for insider sales: the origin of the shares (option grant 02/08/2019), the payment method (cash), broker details (Fidelity), and the required certification about material non-public information. From a governance perspective, the transparent reporting of multiple recent sales and the current planned sale allows investors to see insider liquidity actions but does not include any company-specific operational details or undisclosed adverse facts.